Usefulness of cilostazol versus ticlopidine in coronary artery stenting
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 84 (12) , 1375-1380
- https://doi.org/10.1016/s0002-9149(99)00579-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingNew England Journal of Medicine, 1998
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996
- Prevention of Ischemic StrokeNew England Journal of Medicine, 1995
- CilostazolCardiovascular Drug Reviews, 1993
- Effect of Cilostazol, a Cyclic AMP Phosphodiesterase Inhibitor, on the Proliferation of Rat Aortic Smooth Muscle Cells in CultureJournal of Cardiovascular Pharmacology, 1992
- Angiographic Follow-up after Placement of a Self-Expanding Coronary-Artery StentNew England Journal of Medicine, 1991
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKEThe Lancet, 1989
- Pharmacology of Ticlopidine: A ReviewSeminars in Thrombosis and Hemostasis, 1989
- Effects of Cilostazol, a Selective cAMP Phosphodiesterase Inhibitor on the Contraction of Vascular Smooth MusclePharmacology, 1988